Published on January 15, 2014

North Kansas City Hospital and The University of Kansas Cancer Center Open New Oncology Partnership Offices

A partnership between North Kansas City Hospital and The University of Kansas Cancer Center (KUCC) has opened a fully renovated radiation oncology office and KUCC’s newest medical oncology office on the North Kansas City Hospital campus. Both offices are on the lower level of the Medical Plaza building, 2750 Clay Edwards Dr., offering Northland patients close to home access to the most comprehensive cancer care, including access to National Cancer Institute clinical research trials.

Through the partnership patients gain greater access to treatment options and clinical research trials available only at a National Cancer Institute-designated cancer center. Services include:

  • Prompt access to first appointment with cancer specialists and second-opinion appointments
  • Resources and education tools, including wellness programs, support groups, cancer rehab, palliative care, pain management, hospice, nurse navigator, home health and fatigue management programs
  • Infusion center with a warm, friendly spa-like atmosphere offering heated treatment chairs with personal TV screens, with additional infusion available inside North Kansas City Hospital
  • New state-of-the-art linear accelerator

Last June North Kansas City Hospital and The University of Kansas Cancer Center announced their partnership in the management and operations of the radiation oncology program on the North Kansas City Hospital campus. Additionally, The University of Kansas Cancer Center manages and operates the medical oncology program located next to the radiation oncology office. North Kansas City also recently joined the Midwest Cancer Alliance, the outreach arm of The University of Kansas Cancer Center to support the clinical trials network.

To celebrate the opening, the hospitals will hold a grand opening from 5:30-7:30 p.m. Tuesday, Jan. 21. Guests at the invitation-only open house will include area physicians, hospital executives, local and state elected officials and representatives from area schools, chambers of commerce and economic development councils.

Speakers at a 6 p.m. presentation will include:

Peggy Schmitt, president and CEO, North Kansas City Hospital

Bob Page, president and CEO, The University of Kansas Hospital

Roy Jensen, M.D., director, The University of Kansas Cancer Center



About North Kansas City Hospital: For more than half a century, North Kansas City Hospital has been at the forefront of providing medical care in the Northland. The hospital is an acute-care facility with 451 licensed beds and specialties in cardiac care, cancer care, women’s health, orthopedics, emergency services and minimally invasive surgery. It provides a full continuum of care from the highest level of neonatal intensive care to award-winning cardiovascular and orthopedic programs to home health and hospice. The medical staff includes more than 550 physicians representing 49 medical specialties. 

North Kansas City Hospital is the first hospital in Missouri and one of only a few hospitals in the country to receive the Mission: Lifeline Heart Attack Receiving Center accreditation from the American Heart Association. In addition, the hospital is a major trauma center for emergency care, is rated as one of the busiest adult/pediatric emergency departments in Kansas City, and is an accredited Level III Chest Pain Center through the Society of Cardiovascular Patient Care. 

The University of Kansas Cancer Center, a National Cancer Institute designated center, is transforming cancer research and clinical care by linking an innovative approach to drug discovery, delivery, and development to a nationally recognized patient care program. The partnership includes cancer research and healthcare professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, the University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, and the members of the Midwest Cancer Alliance Partners Advisory Board and Clinical Trials Network. For more information on The University of Kansas Cancer Center’s research and outreach programs, please visit their website or call 1-800-332-6048.